| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 08/08/2013 | WO2013116382A1 Purinone compounds as kinase inhibitors |
| 08/08/2013 | US20130203986 Arylamino Purine Derivatives, Preparation Method and Pharmaceutical Use Thereof |
| 08/08/2013 | US20130203785 Valomaciclovir Polymorphs |
| 08/08/2013 | US20130203767 Treatment of Pulmonary Hypertension |
| 08/08/2013 | US20130202549 Use of dpas and co-polymers for hyperlipidemia and atherosclerosis along with reducing feeding rate and adipose tissue weight of obesity animal |
| 08/07/2013 | EP2623507A1 Morpholino nucleic acid derivative |
| 08/06/2013 | US8501735 N-containing heteroaryl derivatives as JAK3 kinase inhibitors |
| 08/06/2013 | US8501724 Purinone compounds as kinase inhibitors |
| 08/01/2013 | US20130197220 Morpholino Nucleic Acid Derivatives |
| 08/01/2013 | US20130197014 Purinone compounds as kinase inhibitors |
| 08/01/2013 | US20130196989 Compositions and methods for inducing cell dedifferentiation |
| 07/31/2013 | EP2619178A1 Substituted benzamide compounds |
| 07/31/2013 | CN103228632A Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction |
| 07/31/2013 | CN102026970B Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 07/31/2013 | CN101861317B Antihistaminic and antiallergic agent and a method for the production thereof |
| 07/30/2013 | US8497370 Processes for preparing amine salts of sildenafil-analogues and use thereof |
| 07/25/2013 | US20130190320 Heterocyclic compounds and uses as anticancer agents |
| 07/24/2013 | EP2617722A1 Hetero ring-fused imidazole derivative having ampk activating effect |
| 07/24/2013 | EP2616478A2 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo |
| 07/24/2013 | EP2616470A1 Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal applications |
| 07/24/2013 | EP2616469A1 Inhibitors of pi3k-delta and methods of their use and manufacture |
| 07/24/2013 | EP2616444A2 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction |
| 07/24/2013 | EP2616442A1 Inhibitors of pi3k-delta and methods of their use and manufacture |
| 07/24/2013 | CN103221403A Heterocyclic compounds and their uses |
| 07/24/2013 | CN102344451B Method for preparing caffeine |
| 07/24/2013 | CN101663302B Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 07/23/2013 | US8492391 Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives |
| 07/23/2013 | US8492390 Synthesis of locked nucleic acid derivatives |
| 07/23/2013 | US8492389 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/23/2013 | US8492374 Azaazulene compounds |
| 07/18/2013 | WO2013106792A1 Heterocyclic compounds and uses as anticancer agents. |
| 07/18/2013 | US20130184240 Hetero ring-fused imidazole derivative having ampk activating effect |
| 07/18/2013 | US20130184204 Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| 07/17/2013 | EP2614369A2 Inhibitors of human ezh2, and methods of use thereof |
| 07/17/2013 | EP2613631A1 Use of 6 - substituted 9 - halogenalkyl purines for regulation of growth and development of whole plants, plant cells and plant organs; novel 6 - substituted 9 -halogenalkyl purines |
| 07/17/2013 | CN103209981A Hetero ring-fused imidazole derivative having ampk activating effect |
| 07/17/2013 | CN101784548B Purine derivatives and their use as modulators of Toll-like receptor 7 |
| 07/11/2013 | WO2013103601A1 Carbocyclic nucleosides and their pharmaceutical use and compositions |
| 07/11/2013 | WO2012159072A3 Fluorescent molecular probes for use in assays that measure test compound competitive binding with sam-utilizing proteins |
| 07/11/2013 | US20130178485 Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines |
| 07/10/2013 | EP2612862A2 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/10/2013 | EP2611807A2 Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione |
| 07/10/2013 | CN203048833U Active carbon and caffeine separation cracker |
| 07/10/2013 | CN103193778A Preparation methods of N-alkyl valaciclovir compound and its hydrochloride and intermediate |
| 07/09/2013 | US8481728 Process for preparing entecavir and its intermediates |
| 07/04/2013 | WO2013098775A1 Improved process for preparation of pure linagliptin |
| 07/04/2013 | WO2013010136A3 Inhibitors of bruton's tyrosine kinase |
| 07/04/2013 | US20130172340 Substituted 2-(9h-purin-9-yl) acetic acid analogues as inhibitors of stat3 |
| 07/04/2013 | US20130172328 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
| 07/04/2013 | US20130172249 Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal applications |
| 07/02/2013 | US8476285 Purine-core inhibitors of HSP90 and their use in treating cancer |
| 06/27/2013 | WO2013096679A1 Substituted nucleosides, nucleotides and analogs thereof |
| 06/27/2013 | US20130165455 Tlr agonists |
| 06/27/2013 | US20130165428 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/27/2013 | US20130165426 Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators |
| 06/26/2013 | EP2607365A1 Toll-like receptor modulators and treatment of diseases |
| 06/26/2013 | CN103172633A Compound, and preparation method and application thereof |
| 06/25/2013 | US8470805 Processes for preparing piperazinium salts of KMUP and use thereof |
| 06/20/2013 | WO2013087738A1 Novel compounds |
| 06/20/2013 | WO2013058681A3 Substituted phenoxyacetic acids and esters and amides thereof, comprising a 2,6-dioxo-2,3,6,7-tetrahydro-1н-purine-8-yl fragment and constituting а2a adenosine receptor antagonists, and the use thereof |
| 06/20/2013 | WO2013057013A3 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 06/20/2013 | US20130157973 Pharmaceutical compositions and methods for treating gastrointestinal infections and disorders |
| 06/20/2013 | US20130157971 2'-fluoronucleosides |
| 06/20/2013 | US20130156826 Respiratory formulations and compounds for use therein |
| 06/19/2013 | CN103159769A Doxofylline compound and medicine composition thereof |
| 06/19/2013 | CN102344450B Method for extracting theophylline sodium salt or theophylline by styrene type macroporous resin |
| 06/13/2013 | US20130150578 Novel hypoglycemic compounds |
| 06/13/2013 | US20130150383 Novel compounds |
| 06/13/2013 | US20130150364 Heterocyclic compound |
| 06/13/2013 | US20130150355 Novel compounds |
| 06/13/2013 | US20130149283 Methods and compositions for treating hepatitis c virus |
| 06/12/2013 | CN103154009A Morpholino nucleic acid derivative |
| 06/12/2013 | CN103153995A Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors |
| 06/12/2013 | CN103145714A Feather weight PNA (pentose nucleic acid) synthesis method |
| 06/12/2013 | CN103145713A Doxofylline crystalline compound and lyophilized powder thereof |
| 06/12/2013 | CN103145712A Substituted 8-[6-amino-3-pyridyl]xanthenes |
| 06/12/2013 | CN103142603A Isoguanine compound used for treating hepatitis C virus (HCV) |
| 06/12/2013 | CN101896484B Theobromine production process |
| 06/12/2013 | CN101674834B Inhibitors of bruton's tyrosine kinase |
| 06/12/2013 | CN101657453B Purines as PKC-theta inhibitors |
| 06/11/2013 | CA2473864C Composition for use in treating patients suffering from movement disorder |
| 06/06/2013 | WO2013082540A1 Compositions and methods of treating a proliferative disease with a quinazolinone derivative |
| 06/06/2013 | WO2013082028A1 Difluoromethylation of unsaturated compounds |
| 06/06/2013 | WO2013081016A1 Purinone derivative hydrochloride |
| 06/06/2013 | WO2013079460A1 Novel compounds |
| 06/06/2013 | US20130144058 Process for the synthesis of carbonucleoside and intermediates for use therein |
| 06/06/2013 | US20130143902 Compositions and methods of treating a proliferative disease with a quinazolinone derivative |
| 06/06/2013 | CA2857150A1 Purinone derivative hydrochloride |
| 06/05/2013 | CN102329317B Method for synthesizing theobromine |
| 06/05/2013 | CN101998957B Substituted xanthine derivatives |
| 05/30/2013 | WO2013076688A1 A process for the preparation of valacyclovir hydrochloride |
| 05/30/2013 | WO2013076236A1 Process for preparing an antiviral drug and intermediates thereof |
| 05/30/2013 | US20130137694 Novel modulators of nrf2 and uses thereof |
| 05/30/2013 | US20130137688 Novel compounds |
| 05/30/2013 | US20130137648 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 05/30/2013 | US20130133289 Process for the preparation of amorphus valgancyclovir hydrochloride |
| 05/29/2013 | EP2597096A1 Process for preparing entecavir and intermediates thereof |
| 05/29/2013 | CN101565359B Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation |
| 05/23/2013 | WO2013074817A1 Solid state forms of linagliptin |
| 05/23/2013 | WO2013071865A1 Kinase modulating compounds, compositions containing the same and use thereof |